Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
FLDM [NASD]
Fluidigm Corporation
Index- P/E- EPS (ttm)-0.65 Insider Own0.20% Shs Outstand28.02M Perf Week3.99%
Market Cap1.06B Forward P/E- EPS next Y-0.59 Insider Trans-92.89% Shs Float26.16M Perf Month-12.80%
Income-16.50M PEG- EPS next Q-0.31 Inst Own94.60% Short Float4.92% Perf Quarter-7.98%
Sales71.20M P/S14.88 EPS this Y24.40% Inst Trans-1.34% Short Ratio2.99 Perf Half Y55.17%
Book/sh3.75 P/B10.08 EPS next Y39.20% ROA-14.50% Target Price50.50 Perf Year100.21%
Cash/sh3.01 P/C12.55 EPS next 5Y33.00% ROE-16.80% 52W Range15.72 - 49.46 Perf YTD-1.25%
Dividend- P/FCF- EPS past 5Y48.40% ROI-19.40% 52W High-23.57% Beta-
Dividend %- Quick Ratio5.40 Sales past 5Y36.00% Gross Margin71.60% 52W Low140.46% ATR2.14
Employees325 Current Ratio5.80 Sales Q/Q33.10% Oper. Margin-24.40% RSI (14)43.79 Volatility4.75% 6.07%
OptionableYes Debt/Eq0.00 EPS Q/Q-28.60% Profit Margin-23.20% Rel Volume0.42 Prev Close39.46
ShortableYes LT Debt/Eq0.00 EarningsApr 28 Payout- Avg Volume430.46K Price37.80
Recom2.20 SMA20-2.59% SMA50-12.93% SMA20019.10% Volume180,089 Change-4.21%
23-Apr-14Upgrade Mizuho Neutral → Buy $43 → $50
21-Mar-14Reiterated Maxim Group Buy $52 → $65
03-Feb-14Reiterated Oppenheimer Outperform $46 → $52
14-Jan-14Reiterated Mizuho Neutral $30 → $43
18-Dec-13Reiterated Maxim Group Buy $33 → $42
31-Oct-13Reiterated Mizuho Neutral $19 → $30
31-Oct-13Reiterated Maxim Group Buy $26 → $33
02-Aug-13Reiterated Mizuho Neutral $17 → $19
02-Aug-13Reiterated Maxim Group Buy $21 → $23
27-Jun-13Initiated Maxim Group Buy $21
09-Oct-12Downgrade Mizuho Buy → Neutral $17
31-Aug-12Initiated Mizuho Buy $17
27-Jun-12Initiated Cantor Fitzgerald Buy $17
15-Feb-12Reiterated Deutsche Bank Buy $16 → $19.50
05-Oct-11Initiated Oppenheimer Outperform $19
23-Mar-11Initiated Deutsche Bank Buy $19
23-Apr-14 08:00PM  Fluidigm to Announce Q1 2014 Financial Results and Host Conference Call for Investors Business Wire
05:48AM  Fluidigm upgraded by Mizuho Briefing.com
14-Apr-14 12:02PM  Why Fluidigm (FLDM) Stock Is Up Today at TheStreet
07:04AM  Fluidigm upgraded to Outperform from Market Perform at Leerink theflyonthewall.com
09-Apr-14 07:56AM  Fluidigm (FLDM) is now in Oversold Territory Zacks
08-Apr-14 01:33PM  Analyst Bullish On Medical Research, Equipment Stocks at Investor's Business Daily
18-Mar-14 01:04PM  FLUIDIGM CORP Financials EDGAR Online Financials
12-Mar-14 05:01PM  FLUIDIGM CORP Files SEC form 10-K, Annual Report EDGAR Online
10-Mar-14 05:00PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
05-Mar-14 04:28PM  FLUIDIGM CORP Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
28-Feb-14 10:23AM  Bryan Brokmeier Remains Bullish On Life Sciences Tools And Diagnostics Companies at Seeking Alpha
26-Feb-14 09:00AM  Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference Business Wire
09:00AM  Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference
14-Feb-14 05:22PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Off EDGAR Online
06:04AM  FLUIDIGM CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Sec EDGAR Online
13-Feb-14 04:30PM  Fluidigm Completes Acquisition of DVS Sciences Business Wire
04:30PM  Fluidigm Completes Acquisition of DVS Sciences
10-Feb-14 05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% Zacks
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4%
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% Zacks
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4%
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% Zacks
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4%
05:50AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% Zacks
05:50AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4%
07-Feb-14 07:51AM  Fluidigm downgraded at Cowen at theflyonthewall.com -6.43%
12:54AM  Fluidigm's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
06-Feb-14 04:55PM  Q4 2013 Fluidigm Corp Earnings Conference call (Webcast) at Seeking Alpha
04:24PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:00PM  Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013 Business Wire
10:30AM  Insider Trading Alert - CMA, FLDM, CNQR, MFRM And AWAY Traded By Insiders at TheStreet
07:07AM  Q4 2013 Fluidigm Corp Earnings Release - After Market Close CCBN
04-Feb-14 04:13PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati EDGAR Online
03-Feb-14 07:35AM  Fluidigm acquisition positive, says Oppenheimer theflyonthewall.com
07:35AM  Fluidigm acquisition positive, says Oppenheimer
31-Jan-14 06:30PM  Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors Business Wire
06:30PM  Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors
30-Jan-14 01:32PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online +11.56%
01:32PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
08:00AM  Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering Business Wire
08:00AM  Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering
07:01AM  Fluidigm price target raised to $47 from $28 at Cantor theflyonthewall.com
07:01AM  Fluidigm price target raised to $47 from $28 at Cantor
29-Jan-14 08:35AM  Fluidigm announces proposed $175M convertible notes offering at theflyonthewall.com
08:35AM  Fluidigm announces proposed $175M convertible notes offering
08:31AM  Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering Business Wire
08:31AM  Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering
07:13AM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, EDGAR Online
07:13AM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,
07:00AM  Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences Creating a Single-Cell Technology Powerhouse Business Wire
07:00AM  Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences Creating a Single-Cell Technology Powerhouse
23-Jan-14 12:51PM  [video] Wildly bullish on American capitalism: Pro at CNBC
12:51PM  [video] Wildly bullish on American capitalism: Pro
16-Jan-14 11:49AM  Commit To Purchase Fluidigm At $35, Earn 19.8% Annualized Using Options at TheStreet
11:49AM  Commit To Purchase Fluidigm At $35, Earn 19.8% Annualized Using Options
15-Jan-14 04:41PM  Fluidigm Jumps on Guidance Boost Zacks
04:41PM  Fluidigm Jumps on Guidance Boost
14-Jan-14 12:50PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online +7.24%
12:50PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:00AM  Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance Business Wire
09:00AM  Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance
09-Jan-14 05:12AM  Fluidigm: 4 Different Insiders Have Sold Shares During The Last 30 Days at Seeking Alpha
05:12AM  Fluidigm: 4 Different Insiders Have Sold Shares During The Last 30 Days
08-Jan-14 09:00AM  Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference Business Wire
09:00AM  Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference
31-Dec-13 09:30AM  Nature Selects Single-Cell Sequencing as the 2013 Method of the Year Business Wire
09:30AM  Nature Selects Single-Cell Sequencing as the 2013 Method of the Year
24-Dec-13 09:00AM  Fluidigm Launches Single-Cell DNA Sequencing Workflow to Study Somatic Mutations in Heterogenous Samples Business Wire
09:00AM  Fluidigm Launches Single-Cell DNA Sequencing Workflow to Study Somatic Mutations in Heterogenous Samples
19-Dec-13 04:32PM  3 Stocks Near 52-Week Highs Worth Selling at Motley Fool
04:32PM  3 Stocks Near 52-Week Highs Worth Selling
06:28AM  Fluidigm Corp. (FLDM) Soars: Stock Adds 14% in Session Zacks
06:28AM  Fluidigm Corp. (FLDM) Soars: Stock Adds 14% in Session
18-Dec-13 08:02PM  Why Halozyme Therapeutics Inc., Omeros Corp., and Fluidigm Corp. Jumped Today at Motley Fool +14.04%
08:02PM  Why Halozyme Therapeutics Inc., Omeros Corp., and Fluidigm Corp. Jumped Today
07:46AM  Fluidigm price target raised to $42 from $33 at Maxim theflyonthewall.com
07:46AM  Fluidigm price target raised to $42 from $33 at Maxim
12-Dec-13 03:16PM  A Top 10 Wall Street Transcript Portfolio Manager Explains His Method for Achieving 50+% Annual Returns through Investing in Health Care Innovation: An Interview with Finny Kuruvilla, M.D., Ph.D., of the Eventide Gilead Fund Wall Street Transcript
03:16PM  A Top 10 Wall Street Transcript Portfolio Manager Explains His Method for Achieving 50+% Annual Returns through Investing in Health Care Innovation: An Interview with Finny Kuruvilla, M.D., Ph.D., of the Eventide Gilead Fund
09-Dec-13 01:53PM  Genomic Technologies and New Treatments for Hepatitis C Lead Stock Winners for 2013: A Top Ten Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Company Wall Street Transcript
01:53PM  Genomic Technologies and New Treatments for Hepatitis C Lead Stock Winners for 2013: A Top Ten Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Company
27-Nov-13 08:00AM  Fluidigm to Present at the 25th Annual Piper Jaffray Healthcare Conference Business Wire
08:00AM  Fluidigm to Present at the 25th Annual Piper Jaffray Healthcare Conference
14-Nov-13 01:04PM  FLUIDIGM CORP Financials EDGAR Online Financials
01:04PM  FLUIDIGM CORP Financials
07-Nov-13 05:28PM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06-Nov-13 06:30PM  Fluidigm to Present at the Credit Suisse 2013 Healthcare Conference Business Wire
31-Oct-13 08:33AM  Fluidigm price target raised to $33 from $26 at Maxim theflyonthewall.com +24.36%
02:40AM  Fluidigm Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
30-Oct-13 04:22PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:00PM  Fluidigm Reports Financial Results for Third Quarter 2013 Business Wire
07:07AM  Q3 2013 Fluidigm Corp Earnings Release - After Market Close CCBN
17-Oct-13 05:23PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
16-Oct-13 04:30PM  Fluidigm to Announce Q3 2013 Financial Results and Host Conference Call for Investors Business Wire
08-Oct-13 06:35PM  ISRG Rises 4.6%, Near-Term Outlook Still Bleak Zacks
01-Oct-13 04:30PM  InPlay: Fluidigm and NanoString (NSTG) agree to litigation settlement; NSTG to remove all references to a single-cell comparison study comparing Fluidigm and NanoString Briefing.com
04:30PM  NanoString Technologies, Inc. and Fluidigm Corporation Settle Lawsuits GlobeNewswire
04:30PM  Fluidigm and NanoString Agree to Litigation Settlement Business Wire
09-Sep-13 09:00AM  Fluidigm C1 Single-Cell Auto Prep System Wins Prestigious IBO Design Award Business Wire
21-Aug-13 02:09PM  Interview with William Quirk, Managing Director and Senior Research Analyst at Piper Jaffray & Co.: Solid Fundamentals for Diagnostics and Life Science Tools Despite Short-Term Challenges Wall Street Transcript
Fluidigm Corporation develops, manufactures, and sells microfluidic systems worldwide. It offers BioMark HD System that performs high-throughput and single-cell targeted gene expression analysis, single nucleotide polymorphism (SNP) genotyping, and digital polymerase chain reaction (PCR) using Fluidigm DELTAgene and SNPtype assays, other chemistries, and Fluidigm Dynamic Array and Digital Array integrated fluidic circuits (IFCs). The company also provides C1 Single-Cell Auto Prep System, which enables the isolation, processing, and profiling of individual cells for genomic analysis for applications comprising single-cell targeted gene expression, single-cell micro ribonucleic acid (RNA) analysis, single-cell messenger RNA analysis, and single-cell targeted DNA sequencing using the company's C1 Single-Cell Auto Prep Array IFCs and C1 reagent kit. In addition, it offers EP1 System, which performs SNP genotyping using Fluidigm SNPtype assays or TagMan assays, as well as end-point digital PCR using TaqMan assays, and Fluidigm Dynamic Array and Digital Array IFCs; and Access Array System to enable PCR-based target enrichment, barcoding, and the tagging of targeted resequencing libraries. Further, the company provides Dynamic Array, Digital Array, C1 Single-Cell Auto Prep Array, and Access Array IFCs; DELTAgene and SNPtype assays; and Access Array Target-Specific primers. It serves academic institutions; clinical laboratories; and pharmaceutical, biotechnology, and agricultural biotechnology companies in single-cell genomics, applied genotyping, and sample preparation for targeted re sequencing markets. Fluidigm Corporation distributes its products through support organizations, distributors, or sales agents, as well as through its direct sales force. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith William MaxwellEVP, LEGAL AFFAIRS & GCApr 15Option Exercise3.393,00010,1723,000Apr 17 07:01 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCApr 15Sale35.323,000105,9600Apr 17 07:01 PM
Worthington Gajus VincentPRESIDENT & CEOApr 09Option Exercise3.3933,029111,99533,029Apr 11 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERApr 07Option Exercise15.295,09177,8285,091Apr 09 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERApr 07Sale37.515,091190,9630Apr 09 07:00 PM
Worthington Gajus VincentPRESIDENT & CEOApr 01Sale45.126,000270,72235,159Apr 03 07:00 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMar 17Option Exercise2.933,0008,7863,000Mar 18 07:06 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMar 17Sale47.763,000143,2800Mar 18 07:06 PM
Walder Fredric TCHIEF OPERATING OFFICERMar 14Option Exercise8.372,76323,1352,763Mar 18 07:00 PM
Walder Fredric TCHIEF OPERATING OFFICERMar 14Sale46.652,763128,8940Mar 18 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMar 07Option Exercise16.273,95064,2523,950Mar 11 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMar 07Sale48.263,950190,6270Mar 11 07:00 PM
Worthington Gajus VincentPRESIDENT & CEOMar 03Sale45.666,000273,96041,159Mar 05 07:00 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCFeb 18Option Exercise2.423,0007,2663,000Feb 20 07:00 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCFeb 18Sale44.073,000132,2100Feb 20 07:00 PM
Walder Fredric TCHIEF OPERATING OFFICERFeb 14Option Exercise8.372,76323,1352,763Feb 19 07:00 PM
Walder Fredric TCHIEF OPERATING OFFICERFeb 14Sale43.512,763120,2180Feb 19 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 11Option Exercise16.733,95066,0843,950Feb 13 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 11Sale42.083,950166,2300Feb 13 07:00 PM
Worthington Gajus VincentPRESIDENT & CEOFeb 03Sale45.736,000274,36447,159Feb 05 07:00 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTJan 31Option Exercise4.453,50015,5613,500Feb 04 07:00 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTJan 31Sale43.283,500151,4800Feb 04 07:00 PM